Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 566

1.

Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.

Ledwich LJ, Clarke K.

J Clin Rheumatol. 2009 Mar;15(2):61-4. doi: 10.1097/RHU.0b013e31819b65bd.

PMID:
19265346
[PubMed - indexed for MEDLINE]
2.

Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.

Wall E, Walker-Bone K.

QJM. 2008 Apr;101(4):317-23. doi: 10.1093/qjmed/hcm126. Epub 2008 Feb 12.

PMID:
18270228
[PubMed - indexed for MEDLINE]
Free Article
3.

Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.

Cruse LM, Valeriano J, Vasey FB, Carter JD.

J Clin Rheumatol. 2006 Oct;12(5):221-5.

PMID:
17023807
[PubMed - indexed for MEDLINE]
5.

Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.

Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J.

Arthritis Rheum. 2002 Dec;46(12):3136-42.

PMID:
12483716
[PubMed - indexed for MEDLINE]
Free Article
6.

Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice.

Gudbjornsson B, Juliusson UI, Gudjonsson FV.

Ann Rheum Dis. 2002 Jan;61(1):32-6.

PMID:
11779755
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists].

Heberlein I, Demary W, Bloching H, Braun J, Buttgereit F, Dreher R, Kuhn C, Lange U, Zink A, Zeidler H, Häntzschel H, Raspe H.

Z Rheumatol. 2011 Sep;70(7):592-601. doi: 10.1007/s00393-011-0821-7. German.

PMID:
21755301
[PubMed - indexed for MEDLINE]
8.

Management of glucocorticoid-induced osteoporosis in male veterans.

Elliott ME, Farrah RM, Binkley NC, Carnes ML, Gudmundsson A.

Ann Pharmacother. 2000 Dec;34(12):1380-4.

PMID:
11144692
[PubMed - indexed for MEDLINE]
9.

Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis.

Boling EP.

Clin Ther. 2004 Jan;26(1):1-14. Review.

PMID:
14996513
[PubMed - indexed for MEDLINE]
10.

Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.

Feldstein AC, Elmer PJ, Nichols GA, Herson M.

Osteoporos Int. 2005 Dec;16(12):2168-74. Epub 2005 Sep 3.

PMID:
16142501
[PubMed - indexed for MEDLINE]
11.

Cross-sectional study of bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapy.

Liu RH, Albrecht J, Werth VP.

Arch Dermatol. 2006 Jan;142(1):37-41.

PMID:
16415384
[PubMed - indexed for MEDLINE]
12.

Prevention of osteoporosis in glucocorticoid-treated neurology patients.

Lozsadi DA, Peters G, Sadik HY, Kellett MW, Fox SH, Smith DF.

Clin Neurol Neurosurg. 2006 Feb;108(2):157-62. Epub 2005 Nov 21.

PMID:
16303241
[PubMed - indexed for MEDLINE]
13.

Glucocorticoid-induced osteoporosis: unawareness or negligence in India?

Gera C, Vij AS.

Int J Rheum Dis. 2009 Sep;12(3):230-3. doi: 10.1111/j.1756-185X.2009.01415.x.

PMID:
20374351
[PubMed - indexed for MEDLINE]
15.

Compliance with osteoporosis treatment guidelines in postmenopausal women.

Mountjoy CR, Shrader SP, Ragucci KR.

Ann Pharmacother. 2009 Feb;43(2):242-50. doi: 10.1345/aph.1L464. Epub 2009 Feb 5.

PMID:
19196838
[PubMed - indexed for MEDLINE]
16.

Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city.

Caballero-Uribe CV, Acosta-Velez JG, Hernandez-Ruiz EA, Andrade Rodado FM, Peñuela-Epalza M.

J Clin Rheumatol. 2008 Jun;14(3):153-5. doi: 10.1097/RHU.0b013e31816b1931.

PMID:
18525434
[PubMed - indexed for MEDLINE]
17.

Improving trends in glucocorticoid-induced osteoporosis management: 2002 to 2006.

Mohammad A, Ryan JG, Ralph N, Ryan C, O'Connell PG.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):728-33.

PMID:
18078621
[PubMed - indexed for MEDLINE]
18.

Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting.

Yood RA, Harrold LR, Fish L, Cernieux J, Emani S, Conboy E, Gurwitz JH.

Arch Intern Med. 2001 May 28;161(10):1322-7.

PMID:
11371261
[PubMed - indexed for MEDLINE]
19.

The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice.

Walker-Bone K, Wood A, Hull R, Ledingham JM, McCrae FC, Shaban R, Thomas A, Mackay K.

Clin Med. 2004 Sep-Oct;4(5):431-6.

PMID:
15536872
[PubMed - indexed for MEDLINE]
20.

Glucocorticoid-induced osteoporosis: pathogenesis and management.

Nishimura J, Ikuyama S.

J Bone Miner Metab. 2000;18(6):350-2. Review.

PMID:
11052469
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk